TD SYNNEX reports fiscal Q3 results on September 22 with analysts broadly constructive but freshly cautious on margin delivery, after a quarter in which the stock gained about 2.5% but remains slightly softer on the week.
The most telling pre-print move came from Morgan Stanley on September 15. Erik Woodring maintained his Overweight rating but cut his price target to $334 from $374 — a $40 reduction that signals the firm still sees upside from the current $266 level, but has trimmed expectations ahead of the release. That pullback partly offsets the wave of upgrades that followed the June print, when several firms including UBS, Barrington Research, and RBC all raised targets materially after the company's Q2 results. The consensus mean target of $330 implies roughly 24% upside. Barclays, which holds an Equal-Weight rating, nudged its target up to $287 — still below current levels, serving as the ceiling of the bear camp's range. The Street is not unanimously bullish, but it leans that way.
The bull case centers on Hyve. TD SYNNEX's custom server and data-center infrastructure subsidiary has drawn consistent attention as a high-growth offset to the company's more commoditised distribution business. Bulls argue Hyve's new programs and partnerships represent a durable catalyst that the consolidated financials have not yet fully reflected. Bears counter with margin pressure: the bear case explicitly flags a sequential decline in adjusted EBITDA driven by supply-chain lumpiness, along with sluggishness in the PC and networking markets. The EV/EBITDA multiple of roughly 8.9x and a PE near 12.7x leave the stock modestly valued — a cushion for bulls, but not enough to fully insulate against a guidance miss in bears' view.
The prior quarter set a punishing precedent worth noting. After the June earnings event, the stock fell roughly 6% in a single session and extended to nearly -14% over the following five days — the sharpest multi-day reaction in recent history. That drawdown came despite an ultimately constructive analyst response, suggesting the market was disappointed by something in the detail. Institutional ownership offers mild reassurance: T. Rowe Price added over 2.5 million shares as recently as September 1, making it one of the most notable recent additions among major holders. FMR also lifted its stake to around 8% of the company. Insider activity is less directional — Dennis Polk, Chair of Hyve Solutions, sold roughly 2,500 shares across multiple tranches on September 15 under a pre-arranged 10b5-1 plan, which limits the signal value of those transactions.
Positioning heading into the print is genuinely relaxed. Short interest at 2% of free float has fallen 6% over the past week and remains minimal. Borrow availability is effectively unconstrained — over 79 million shares available to lend — and cost to borrow has dropped 41% in a week to just 0.28%. Options are similarly calm: the put/call ratio at 0.19 is barely above its 20-day average, a z-score of just 0.12, indicating no unusual demand for downside protection. The September 22 report therefore tests not whether SNX can deliver growth, but whether Hyve's margin contribution is recovering fast enough to justify the recovery the stock has already priced in since June.
See the live data behind this article on ORTEX.
Open SNX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
